However, ezrin and ezrinTyr-353 expression statuses were not related with the overall survival times of patients with NSCLC (P = 0.076 and P = 0.093, respectively, log-rank) (Figure 3). This evidence concerns the gene EZR and non-small cell lung carcinoma.